Coagulation reference ranges: Difference between revisions
Jump to navigation
Jump to search
(Updated D Dimer ranges to age-specific) |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 13: | Line 13: | ||
|Seconds | |Seconds | ||
|24-38 | |24-38 | ||
| | |60 - 100 secs | ||
|- | |- | ||
|FIBRINOGEN | |FIBRINOGEN | ||
| Line 29: | Line 29: | ||
|<50 yrs 500 | |<50 yrs 500 | ||
51-60yrs 600 | 51-60yrs 600 | ||
61-70yrs 700 | 61-70yrs 700 | ||
71-80yrs 800 | 71-80yrs 800 | ||
>80yrs 900 | >80yrs 900 | ||
|N/A | |N/A | ||
| Line 42: | Line 45: | ||
Reviewed August | Reviewed August 2026 | ||
Latest revision as of 02:27, 7 August 2026
| Parameter | Units | Normal range | Therapeutic range |
| INR | Ratio | 0.8 - 1.2 | 2.0 - 3.0* |
| APTT | Seconds | 24-38 | 60 - 100 secs |
| FIBRINOGEN | g/L | 1.5-4.0 | N/A |
| TCT | Seconds | 15 - 21 | N/A |
| D DIMER | ug/L | <50 yrs 500
51-60yrs 600 61-70yrs 700 71-80yrs 800 >80yrs 900 |
N/A |
| FVIII | iu/dl | 50 - 150 | N/A |
*The INR therapeutic range may be higher for conditions such as heart valves, recurrent thromboembolism or arterial thromboembolism with associated antiphospholipid syndrome.
Reviewed August 2026